Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MedTech
Biotech
Chugai inks $250M deal for Gero’s age-related disease targets
Chugai offered up to $250 million for the chance to develop antibodies against age-related disease targets identified by Gero's AI-driven platform.
Nick Paul Taylor
Jul 7, 2025 3:00am
PFA developer Field Medical raises $35M in quick-turn VC round
Jul 3, 2025 10:30am
FDA clears Fasikl AI stimulation wristwatch for essential tremor
Jul 3, 2025 9:15am
Intuitive’s da Vinci 5 robot bound for Europe after CE Mark
Jul 2, 2025 11:37am
Kardium raises $250M as its afib system undergoes FDA review
Jul 2, 2025 11:00am
Catalio bankrolls biotechs with $400M-plus fund
Jul 1, 2025 4:12pm
